South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent’s roughly 60,000 users are in the country. This article delves into the first six weeks of the LEN rollout, examining user demographics, its effect on overall HIV prevention uptake, and the country’s dose supply.